Immuno-Biological Laboratories (4570) · InitiativeRestated
Production of Proteins Used as Raw Materials for Veterinary Drugs Using Genetically Modified Silkworms
First written in FY2018-Q2. 1 of 2 entries say "Restated". Latest entry: FY2020.
2entries
4years
0from disclosures
How it moved
Same theme, other companies
Practical application and expanded uses of genetically modified silkworm technologyA theme 2 companies write about · 0 as a headwind · 3 as a tailwind
1 other company's latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2020RestatedAnnual report
「The company is working with an animal health pharmaceutical manufacturer to produce proteins used as raw materials for animal health pharmaceuticals using genetically modified silkworms.」
The company continues to pursue the joint production and commercialization of proteins used as raw materials for animal health pharmaceuticals. - FY2018-Q2First statedAnnual report
「The company is working jointly with a veterinary pharmaceutical manufacturer to produce proteins for use as raw materials for veterinary pharmaceuticals using genetically modified silkworms. It aims to maximize the advantages of genetically modified silkworm production technology and use the resulting proteins as raw materials for veterinary pharmaceuticals requiring high levels of safety and efficacy.」
In collaboration with an animal health pharmaceutical manufacturer, the company aims to produce and commercialize proteins used as raw materials for animal health pharmaceuticals using genetically modified silkworms.